{ "cik": 886163, "cik_padded": "0000886163", "entityName": "LIGAND PHARMACEUTICALS INC", "fiscal_years": [ { "accn": "0000886163-26-000006", "filed": "2026-02-27", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 15000000.0, "capex": 452000.0, "cash": 174927000.0, "eps_diluted": 6.13, "free_cash_flow": 48907000.0, "net_income": 124453000.0, "operating_cash_flow": 49359000.0, "operating_income": 41002000.0, "revenue": 268087000.0, "stockholders_equity": 1017212000.0, "total_assets": 1560637000.0, "total_liabilities": 543425000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5342298360617059, "net_margin": 0.46422616538660955, "operating_margin": 0.1529428879430931, "revenue_growth_yoy": 0.6040339131111151, "roa_avg2y": 0.09946647453196138, "roa_period_end": 0.07974500156026033, "roe_avg2y": 0.13471483521509203, "roe_period_end": 0.12234716067053869 } }, { "accn": "0000886163-26-000006", "filed": "2026-02-27", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 1821000.0, "cash": 72307000.0, "eps_diluted": -0.22, "free_cash_flow": 95226000.0, "net_income": -4032000.0, "operating_cash_flow": 97047000.0, "operating_income": -22606000.0, "revenue": 167133000.0, "stockholders_equity": 830439000.0, "total_assets": 941774000.0, "total_liabilities": 111335000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1340676437402386, "net_margin": -0.02412449964997936, "operating_margin": -0.1352575493768436, "revenue_growth_yoy": 0.2727736570358073, "roa_avg2y": -0.004663994586434855, "roa_period_end": -0.004281281921140316, "roe_avg2y": -0.005265934938537972, "roe_period_end": -0.00485526330049528 } }, { "accn": "0000886163-26-000006", "filed": "2026-02-27", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 3521000.0, "cash": 22954000.0, "eps_diluted": 2.94, "free_cash_flow": 46056000.0, "net_income": 52154000.0, "operating_cash_flow": 49577000.0, "operating_income": 11942000.0, "revenue": 131314000.0, "stockholders_equity": 700913000.0, "total_assets": 787216000.0, "total_liabilities": 86303000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.12312940407725352, "net_margin": 0.39717014179752347, "operating_margin": 0.09094232145848881, "revenue_growth_yoy": -0.3308670284593238, "roa_avg2y": 0.0673005205550867, "roa_period_end": 0.0662511940814211, "roe_avg2y": 0.08033592165114241, "roe_period_end": 0.07440866412807295 } }, { "accn": "0000886163-26-000006", "filed": "2026-02-27", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 17923000.0, "cash": 45006000.0, "eps_diluted": -1.98, "free_cash_flow": 119927000.0, "net_income": -33361000.0, "operating_cash_flow": 137850000.0, "operating_income": 3037000.0, "revenue": 196245000.0, "stockholders_equity": 597485000.0, "total_assets": 762668000.0, "total_liabilities": 165183000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.27646384428060955, "net_margin": -0.16999668781370225, "operating_margin": 0.015475553517287067, "revenue_growth_yoy": -0.18753933030834963, "roa_avg2y": -0.03238526436980223, "roa_period_end": -0.04374249345717927, "roe_avg2y": -0.04703223641731118, "roe_period_end": -0.055835711356770464 } }, { "accn": "0000886163-25-000012", "filed": "2025-02-28", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 8761000.0, "cash": 19522000.0, "eps_diluted": 3.31, "free_cash_flow": 70037000.0, "net_income": 57138000.0, "operating_cash_flow": 78798000.0, "operating_income": 103851000.0, "revenue": 241544000.0, "stockholders_equity": 821159000.0, "total_assets": 1297590000.0, "total_liabilities": 476431000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5801933608472902, "net_margin": 0.23655317457688865, "operating_margin": 0.4299465107806445, "revenue_growth_yoy": 0.47677333365940744, "roa_avg2y": 0.042962921189905544, "roa_period_end": 0.044033939842323074, "roe_avg2y": 0.07465682008827426, "roe_period_end": 0.0695821393907879 } }, { "accn": "0000886163-24-000009", "filed": "2024-02-29", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 77998000.0, "capex": 4458000.0, "cash": 47619000.0, "eps_diluted": -0.18, "free_cash_flow": 50128000.0, "net_income": -2985000.0, "operating_cash_flow": 54586000.0, "operating_income": 37500000.0, "revenue": 163562000.0, "stockholders_equity": 709525000.0, "total_assets": 1362285000.0, "total_liabilities": 652760000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.9199957718191748, "net_margin": -0.018249960259718027, "operating_margin": 0.22927085753414608, "roa_avg2y": -0.0020894582108357835, "roa_period_end": -0.0021911714509078497, "roe_avg2y": -0.004042642086680476, "roe_period_end": -0.004207039921073958 } }, { "accn": "0000886163-23-000007", "filed": "2023-02-28", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 453048000.0, "capex": 2553000.0, "cash": 71543000.0, "eps_diluted": 31.85, "free_cash_flow": -31889000.0, "net_income": 629302000.0, "operating_cash_flow": -29336000.0, "operating_income": 807076000.0, "stockholders_equity": 767232000.0, "total_assets": 1494915000.0, "total_liabilities": 727683000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.9484523586086087, "roa_avg2y": 0.4567245269653862, "roa_period_end": 0.4209617269209286, "roe_avg2y": 0.9476397926131616, "roe_period_end": 0.8202238697030364 } }, { "accn": "0000886163-22-000030", "filed": "2022-02-28", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 122868000.0, "capex": 887000.0, "cash": 117164000.0, "eps_diluted": 5.96, "free_cash_flow": 193172000.0, "net_income": 143321000.0, "operating_cash_flow": 194059000.0, "operating_income": 163727000.0, "revenue": 251453000.0, "stockholders_equity": 560914000.0, "total_assets": 1260803000.0, "total_liabilities": 699889000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.2477652545666538, "net_margin": 0.569971326649513, "operating_margin": 0.6511236692344096, "revenue_growth_yoy": 0.7820654561948094, "roa_avg2y": 0.14837894135283544, "roa_period_end": 0.11367438053367578, "roe_avg2y": 0.29836723562561546, "roe_period_end": 0.25551332289798434 } }, { "accn": "0000886163-20-000025", "filed": "2020-02-27", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 1966000.0, "capex": 2156000.0, "cash": 20620000.0, "eps_diluted": 0.53, "free_cash_flow": 86414000.0, "net_income": 12556000.0, "operating_cash_flow": 88570000.0, "operating_income": 68076000.0, "revenue": 141102000.0, "stockholders_equity": 399788000.0, "total_assets": 671021000.0, "total_liabilities": 252374000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6312695728736231, "net_margin": 0.08898527306487505, "operating_margin": 0.48245949738487054, "revenue_growth_yoy": 0.29483450028906244, "roa_avg2y": 0.01973273739083424, "roa_period_end": 0.01871178398291559, "roe_avg2y": 0.03388577180809577, "roe_period_end": 0.03140664552212673 } }, { "accn": "0000886163-19-000041", "filed": "2019-02-28", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 3901000.0, "capex": 1850000.0, "cash": 18752000.0, "eps_diluted": -0.08, "free_cash_flow": 58883000.0, "net_income": -1636000.0, "operating_cash_flow": 60733000.0, "operating_income": 43885000.0, "revenue": 108973000.0, "stockholders_equity": 341290000.0, "total_assets": 601585000.0, "total_liabilities": 230732000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6760584839872249, "net_margin": -0.015012893101961036, "operating_margin": 0.40271443385058686, "roa_period_end": -0.002719482699867849, "roe_period_end": -0.004793577309619385 } } ], "latest_filing": { "accn": "0000886163-26-000006", "filed": "2026-02-27", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000886163.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0000886163.json" }, "ticker": "LGND" }